Home » Topics » BioWorld Science

BioWorld Science
RSS

Flavonoid consumption associated with reduced incidence of COPD

Aug. 20, 2001

Phase I study successful for Prescient NeuroPharma's anhydrovinblastine

Aug. 20, 2001

Schering-Plough and Roche resolve peginterferon patent disputes

Aug. 20, 2001

Phase I trial initiated for Inspire's sinusitis therapy

Aug. 20, 2001

Five statins available in the U.S. as alternatives to Baycol

Aug. 20, 2001

Geron and Kyowa Hakko select telomerase inhibitor for development

Aug. 20, 2001

Encouraging phase I results reported for Supratek's lead oncology product

Aug. 20, 2001

Onyx regains development rights for nonintravenous administration of ONYX-015

Aug. 20, 2001

BioCryst's oral influenza neuraminidase inhibitor to enter phase III trial in U.S.

Aug. 20, 2001

LAR formulations of Amylin's synthetic exendin-4 offer potential for monthly dosing

Aug. 20, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...